CreditReports.dk
HomeScreen companies

Nasal Innovation Systems ApS Financials, key figures and credit report

CVR number: 37904724 Established 2016 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Sandagervej 1, 8240 Risskov
Gross profit -81.9 kDKK FY 2024 -730.4% vs 2023
EBIT - 488.2 kDKK FY 2024 -4,852.6% vs 2023
Net debt 544.7 kDKK FY 2024 +14.4% vs 2023
Quick ratio 0.0 FY 2024 -0 vs 2023

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales
Gross profit-7.55-7.00-9.38-9.86-81.86
Total depreciation- 406.37
EBIT-7.55-7.00-9.38-9.86- 488.23
Other financial expenses-14.35-17.12-24.80
Pre-tax profit-21.90-24.12-34.19-9.86- 488.23
Income taxes-2.00-13.0089.00
Net earnings-21.90-26.12-47.19-9.86- 399.23

Assets (kDKK)

2020
2021
2022
2023
2024
Development expenditure334.80381.52406.37406.37
Intangible assets total334.80381.52406.37406.37
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables23.6613.4313.4313.43
Short term receivables total23.6613.4313.4313.43
Cash and bank deposits6.03102.28211.524.873.68
Cash and cash equivalents6.03102.28211.524.873.68
Balance sheet total (assets)364.50497.23631.31424.673.68

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital50.0050.0050.0050.0050.00
Other reserves279.28315.72316.97316.97
Retained earnings- 377.74- 436.08- 463.44- 510.63- 203.52
Profit of the financial year-21.90-26.12-47.19-9.86- 399.23
Shareholders equity total-70.36-96.47- 143.66- 153.52- 552.74
Provisions74.0076.0089.0089.00
Non-current liabilities total
Current trade creditors8.008.008.008.008.00
Current owed to participating285.28439.43604.84408.05475.29
Current owed to group member67.5770.2873.1473.1473.14
Current liabilities total360.85517.70685.97489.19556.42
Balance sheet total (liabilities)364.50497.23631.31424.673.68
Page generated